ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
166.44
-2.75 (-1.63%)
At close: Aug 1, 2025, 4:00 PM
166.46
+0.02 (0.01%)
After-hours: Aug 1, 2025, 7:32 PM EDT
R1 RCM Employees
ICON Public Limited Company had 41,900 employees as of December 31, 2024. The number of employees increased by 800 or 1.95% compared to the previous year.
Employees
41,900
Change (1Y)
800
Growth (1Y)
1.95%
Revenue / Employee
$193,074
Profits / Employee
$18,956
Market Cap
12.94B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41,900 | 800 | 1.95% |
Dec 31, 2023 | 41,100 | 0 | - |
Dec 31, 2022 | 41,100 | 2,770 | 7.23% |
Dec 31, 2021 | 38,330 | 22,600 | 143.67% |
Dec 31, 2020 | 15,730 | 1,080 | 7.37% |
Dec 31, 2019 | 14,650 | 980 | 7.17% |
Dec 31, 2018 | 13,670 | 420 | 3.17% |
Dec 31, 2017 | 13,250 | 750 | 6.00% |
Dec 31, 2016 | 12,500 | 600 | 5.04% |
Dec 31, 2015 | 11,900 | 1,300 | 12.26% |
Dec 31, 2014 | 10,600 | 300 | 2.91% |
Dec 31, 2013 | 10,300 | 800 | 8.42% |
Dec 31, 2012 | 9,500 | 1,030 | 12.16% |
Dec 31, 2011 | 8,470 | 735 | 9.50% |
Dec 31, 2010 | 7,735 | 565 | 7.88% |
Dec 31, 2009 | 7,170 | 195 | 2.80% |
Dec 31, 2008 | 6,975 | 1,365 | 24.33% |
Dec 31, 2007 | 5,610 | 1,320 | 30.77% |
Dec 31, 2006 | 4,290 | 1,254 | 41.30% |
Dec 31, 2005 | 3,036 | 604 | 24.84% |
May 31, 2004 | 2,432 | 152 | 6.67% |
May 31, 2003 | 2,280 | 643 | 39.28% |
May 31, 2002 | 1,637 | 375 | 29.71% |
May 31, 2001 | 1,262 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ICLR News
- 8 days ago - ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - ICON: Lower Guidance Downside And Expanded Repurchase Plan - Seeking Alpha
- 9 days ago - ICON Announces Results of Annual General Meeting - Business Wire
- 9 days ago - ICON Reports Second Quarter 2025 Results - Business Wire
- 16 days ago - ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report - Business Wire
- 25 days ago - ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability - Business Wire
- 5 weeks ago - ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued? - Seeking Alpha
- 5 weeks ago - ICON plc Schedules Second Quarter 2025 Earnings Conference Call - Business Wire